136 related articles for article (PubMed ID: 25329633)
1. Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors.
Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
Tissue Antigens; 2014 Nov; 84(5):471-8. PubMed ID: 25329633
[TBL] [Abstract][Full Text] [Related]
2. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
Sanjeevi S; Sun C; Kanungo A; Sanjeevi CB
Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
[TBL] [Abstract][Full Text] [Related]
3. Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.
Jobim M; Chagastelles P; Salim PH; Portela P; Wilson TJ; Curti AG; Jobim MR; João DA; Nardi NB; Tschiedel B; Jobim LF; Roesler R; Schwartsmann G
Hum Immunol; 2010 Aug; 71(8):799-803. PubMed ID: 20580654
[TBL] [Abstract][Full Text] [Related]
4. Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease.
Díaz-Peña R; Vidal-Castiñeira JR; Moro-García MA; Alonso-Arias R; Castro-Santos P
Hum Immunol; 2016 Jan; 77(1):104-109. PubMed ID: 26542067
[TBL] [Abstract][Full Text] [Related]
5. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes.
Bratanic N; Smigoc Schweiger D; Mendez A; Bratina N; Battelino T; Vidan-Jeras B
Tissue Antigens; 2010 Sep; 76(3):208-15. PubMed ID: 20492597
[TBL] [Abstract][Full Text] [Related]
6. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053
[TBL] [Abstract][Full Text] [Related]
7. Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding.
Ramos-Lopez E; Scholten F; Aminkeng F; Wild C; Kalhes H; Seidl C; Tonn T; Van der Auwera B; Badenhoop K
Tissue Antigens; 2009 Jun; 73(6):599-603. PubMed ID: 19392800
[TBL] [Abstract][Full Text] [Related]
8. When type 1 diabetes meets celiac disease.
Vidan-Jeras B
HLA; 2018 Dec; 92 Suppl 2():64-66. PubMed ID: 30488586
[TBL] [Abstract][Full Text] [Related]
9. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
10. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.
Al Omar S; Middleton D; Marshall E; Porter D; Xinarianos G; Raji O; Field JK; Christmas SE
Hum Immunol; 2010 Oct; 71(10):976-81. PubMed ID: 20600442
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
12. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
13. Contribution of KIR genes, HLA class I ligands, and KIR/HLA class I ligand combinations on the genetic predisposition to celiac disease and coexisting celiac disease and type 1 diabetes mellitus.
Akar HH; Patiroglu T; Sevinc E; Aslan D; Okdemir D; Kurtoglu S
Rev Esp Enferm Dig; 2015 Sep; 107(9):547-53. PubMed ID: 26334461
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.
Hollenbach JA; Ladner MB; Saeteurn K; Taylor KD; Mei L; Haritunians T; McGovern DP; Erlich HA; Rotter JI; Trachtenberg EA
Immunogenetics; 2009 Oct; 61(10):663-71. PubMed ID: 19789864
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
Roberts CH; Molina S; Makalo P; Joof H; Harding-Esch EM; Burr SE; Mabey DC; Bailey RL; Burton MJ; Holland MJ
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2744. PubMed ID: 24651768
[TBL] [Abstract][Full Text] [Related]
16. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
[TBL] [Abstract][Full Text] [Related]
17. Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).
Osman AE; Eltayeb-ELSheikh N; Mubasher M; Al Harthi H; Alharbi S; Hamza MA; ElGhazali G
Hum Immunol; 2016 Jan; 77(1):110-114. PubMed ID: 26542066
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
19. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls.
Nikitina-Zake L; Rajalingham R; Rumba I; Sanjeevi CB
Ann N Y Acad Sci; 2004 Dec; 1037():161-9. PubMed ID: 15699512
[TBL] [Abstract][Full Text] [Related]
20. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
